1. Home
  2. SCPH vs FVCB Comparison

SCPH vs FVCB Comparison

Compare SCPH & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • FVCB
  • Stock Information
  • Founded
  • SCPH 2013
  • FVCB 2007
  • Country
  • SCPH United States
  • FVCB United States
  • Employees
  • SCPH N/A
  • FVCB N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • FVCB Major Banks
  • Sector
  • SCPH Health Care
  • FVCB Finance
  • Exchange
  • SCPH Nasdaq
  • FVCB Nasdaq
  • Market Cap
  • SCPH 299.0M
  • FVCB 240.3M
  • IPO Year
  • SCPH 2017
  • FVCB N/A
  • Fundamental
  • Price
  • SCPH $5.63
  • FVCB $13.30
  • Analyst Decision
  • SCPH Buy
  • FVCB Buy
  • Analyst Count
  • SCPH 3
  • FVCB 1
  • Target Price
  • SCPH $12.00
  • FVCB $16.00
  • AVG Volume (30 Days)
  • SCPH 2.4M
  • FVCB 37.0K
  • Earning Date
  • SCPH 11-12-2025
  • FVCB 10-21-2025
  • Dividend Yield
  • SCPH N/A
  • FVCB 1.78%
  • EPS Growth
  • SCPH N/A
  • FVCB 359.39
  • EPS
  • SCPH N/A
  • FVCB 1.11
  • Revenue
  • SCPH $49,969,000.00
  • FVCB $62,780,000.00
  • Revenue This Year
  • SCPH $104.30
  • FVCB $10.08
  • Revenue Next Year
  • SCPH $76.06
  • FVCB $7.22
  • P/E Ratio
  • SCPH N/A
  • FVCB $12.17
  • Revenue Growth
  • SCPH 107.79
  • FVCB 40.73
  • 52 Week Low
  • SCPH $1.94
  • FVCB $9.49
  • 52 Week High
  • SCPH $6.28
  • FVCB $14.50
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 63.97
  • FVCB 51.28
  • Support Level
  • SCPH $4.33
  • FVCB $13.20
  • Resistance Level
  • SCPH $5.62
  • FVCB $13.60
  • Average True Range (ATR)
  • SCPH 0.04
  • FVCB 0.29
  • MACD
  • SCPH -0.01
  • FVCB -0.03
  • Stochastic Oscillator
  • SCPH 86.67
  • FVCB 34.47

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: